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LONG NON-CODING RNAS IN OSTEOARTHRITIS AND
CHONDROGENESIS
M.J. Barter y, S. Hyatt z, Y. Xu y, D.A. Young y. yNewcastle Univ., Newcastle
upon Tyne, United Kingdom; zCardiff Univ., Cardiff, United Kingdom
Purpose: Since the advent of the genomic age extensive character-
isation of the transcriptome has indicated the abundance of long non-
coding RNAs (lncRNAs) derived from both intergenic and overlapping
protein-coding gene regions. lncRNAs are expressed in a highly tissue-
speciﬁc manner where they function in various aspects of cell biology.
Although only a fraction have been functionally validated lncRNAs have
emerged as key regulators of gene expression, acting through diverse
mechanisms such as the regulation of epigenetic modiﬁcations and by
acting as scaffolds for protein complex formation at gene loci. The
abundance of lncRNAs in cartilage has yet to be established and
accordingly the potential dysregulation of lncRNA expression in carti-
lage pathology is not yet appreciated. Thus the aims of this study are to
illuminate the chondrocyte non-coding transcriptome, examine alter-
ations during osteoarthritis (OA) and establish functions for lncRNAs in
chondrocyte biology.
Methods: RNA sequencing was performed on human articular cartilage
RNA from patients with end-stage hip OA or neck of femur fracture
(NOF). Sequencing was performed by Illumina Genome Analyzer IIx and
reads aligned to the human genome. Bioconductor packages were used
for normalization and to identify differentially expressed transcripts.
lncRNA expression was validated by real-time RT-PCR. Regulation of
lncRNAs was examined during differentiation of human mesenchymal
stem cells (hMSCs) into chondrocytes, in comparison with adipocytes
and osteoblasts. The role of selected lncRNAs following targeted RNA
interference (RNAi) and overexpression was established in humanchondrocytes and during hMSC chondrogenesis. Cartilage assays such
as the DMB glycosaminoglycan assay and hydroxyproline assay were
used in combinationwith RNA expression and histochemical analysis of
cartilage components.
Results: We have identiﬁed the expression of 5000þ lncRNAs in car-
tilage tissue of which 134 appear differentially expressed in OA
compared with NOF (>2 fold change, Benjamini-Hochberg corrected P
value of < 0.05). In addition we have identiﬁed a number of robustly
expressed novel lncRNAs potentially speciﬁc to the chondrocyte
phenotype. Of particular interest are a group of lncRNAs which sur-
round the master chondrocyte transcription factor SOX9 locus. We
conﬁrmed the presence of these novel lncRNAs in chondrocytes and
examined their expression in a number of additional joint tissues and
during differentiation of hMSCs. Many are speciﬁcally induced during
hMSC chondrogenesis correlating with the induction of SOX9 itself.
Depletion of select lncRNAs by RNAi disrupted hMSC chondrogenesis,
concomitant with reduced cartilage gene expression and matrix
component production, indicating an essential role in chondrocyte
biology.
Conclusions: We have characterised the chondrocyte non-coding
transcriptome and identiﬁed a number of novel lncRNAs. Osteoarthritic
tissue exhibits alterations in lncRNA expression and a number of
robustly expressed chondrocyte lncRNAs have critical roles in chon-
drocyte biology. Our ongoing examination into the mechanisms of
lncRNA function will shed light on chondrocyte gene regulation and
provide a greater understanding of mechanisms which may become
disrupted during the development of osteoarthritis.
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INTERLEUKIN-1B IS ESSENTIAL FOR BLOOD-INDUCED CARTILAGE
DAMAGE IN VITRO
L.F. van Vulpen, G. Roosendaal, R.E. Schutgens, S.C. Mastbergen,
F.P. Lafeber. UMC Utrecht, Utrecht, Netherlands
Purpose: Exposure of joint cartilage to blood can occur after joint
trauma, during or after major joint surgery, or due to hemophilia.
This ultimately leads to joint damage, both by direct effects of
blood on cartilage and via synovial inﬂammation. Cartilage
destruction is considered to result from both cartilage matrix-
degrading proteases as well as cartilage-destructive pro-inﬂamma-
tory cytokines such as IL1b. To unravel the role of IL1b in the
pathogenesis of blood-induced cartilage damage, we investigated
whether direct blocking of IL1b speciﬁcally prevents blood-induced
cartilage damage in vitro.
Methods: Full thickness healthy human articular cartilage explants,
obtained post-mortem, were cultured for 4 days in presence or absence
of 50% v/v whole blood. A recombinant human IL1b monoclonal anti-
body (IL1b mAb) was only added during blood exposure in a concen-
tration of 0, 1, 2, 10, 30, or 100 ng/mL. Cartilage matrix proteoglycan
turnover was determined 12 days later to analyse long-term effects.
Moreover, to investigate the direct effects of IL1b mAb on cartilage,
explants were cultured for 4 days in the presence of 10 ng/mL IL1bmAb
in the absence of blood.
Results: Exposure to blood decreased the proteoglycan-synthesis rate
(-62%) and proteoglycan content (-19%), and increased the proteoglycan
release (þ191%, all p < 0.05). Adding IL1bmAb resulted in a dose-
dependent increase of the proteoglycan synthesis rate leading to nor-
malisation at higher concentrations (see ﬁgure A). Moreover, proteo-
glycan release was statistically signiﬁcantly decreased from a
concentration of 3ng/mL and above (see ﬁgure B). Similar, the proteo-
glycan content increased statistically signiﬁcantly upon addition of the
IL1bmAb (3 ng/mL and above; all p < 0.05). In the absence of blood,
IL1bmAb did not have direct effects on cartilage proteoglycan turnover
(p ¼ 0.51).
Conclusions: This study demonstrates that IL1b is a crucial factor in
the development of blood-induced cartilage damage in vitro. Blocking
this pro-inﬂammatory cytokine with a monoclonal antibody protects
cartilage from the damaging effects of blood exposure. Further
research is warranted to investigate the in vivo capacity of IL1b mAb
in prevention and its position as a treatment of hemophilic
arthropathy.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S140Figure - Effect of IL 1b mAb on cartilage proteoglycan synthesis rate (A)
and – release (B). Median values  IQR of 6 individual cartilage and blood
donors are shown. Hash tags indicate a statistically signiﬁcant difference
from control values, whereas asterisks indicate a statistically signiﬁcant
difference from blood-exposed cartilage without IL 1b mAb addition (p <
0.05).
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CONCENTRATION DEPENDENT CARTILAGE BOUNDARY LUBRICATING
ABILITY OF PROTEOGLYCAN 4 MONOMERS AND MULTIMERS
S. Abubacker, T.A. Schmidt. Univ. of Calgary, Calgary, AB, Canada
Purpose: Proteoglycan 4 (PRG4) is a mucin-like glycoprotein that exists
in synovial ﬂuid (SF) as monomeric (PRG4-mono) and multimeric
(PRG4-multi) forms. PRG4 is present at the surface of articular cartilage
where it functions as a critical boundary lubricant in a dose-dependent
manner, and is necessary for joint health. The ability to form disulﬁde-
bonded multimers is a functionally determinant property for many
mucins, and this appears to be true for PRG4.We have previously shown
that PRG4-multi is a more effective cartilage boundary lubricant com-
pared to PRG4-mono at the same physiological concentration (450 mg
/mL), suggesting inter-molecular disulﬁde bonds are important for
boundary lubrication function. However, the potential dose-depend-
ence of PRG4-multi’s and PRG4-mono’s cartilage boundary lubricating
ability remains unknown. Therefore, the objective of this study was to
analyse the cartilage boundary lubricating ability of PRG4-mono and
PRG4-multi over a range of pathophysiological concentrations.
Methods: PRG4 was puriﬁed frommedia conditioned bymature bovine
cartilage explants. Enriched non-reduced PRG4-mono and -multi were
prepared using size exclusion chromatography (SEC) (Sephacryl S-500,
XK16/100 column) with PBSþ0.25%CHAPS. The cartilage boundary
lubricating ability of the enriched preparations was assessed using an in
vitro cartilage-cartilage friction test under boundary lubricating con-
ditions. Kinetic (< mkinetic,Neq>) friction coefﬁcient were then
calculated.
Test sequences:
PRG4-mono dose-response (n ¼ 4): PBS, 45 mg/mL, 150 mg/mL, 450 mg/
mL, SF
PRG4-multi dose-response (n ¼ 4): PBS, 45 mg/mL, 150 mg/mL, 450 mg/
mL, SF
Statistical Analysis: Data are presented as mean  SEM. ANOVA was
used to assess the effect of lubricant and pre-sliding duration (Tps), as a
repeated factor, on < mkinetic,Neq> with Fisher’s post-hoc testing at
Tps ¼ 1.2s on PRG4-multi and -mono dose-responses.
Results: < mkinetic,Neq> values for both PRG4-mono and -multi varied
with lubricant and Tps (both p < 0.05) increasing only slightly with Tps,
with no interaction (both p > 0.05). < mkinetic,Neq> values at Tps ¼
1.2s for PRG4-mono at 45 mg/mL (0.159  0.022), 150 mg/mL (0.142 
0.014) and 450 mg/mL (0.145  0.027) were not signiﬁcantly different
from each other (p> 0.05). However, PRG4-multi at 450 mg/mL (0.090
0.007) was signiﬁcantly lower than PRG4-multi at 45 mg/mL (0.163 
0.023, p < 0.01) and 150 mg/mL (0.144  0.011, p < 0.05). There was no
signiﬁcant difference between PRG4-multi at 45 mg/mL and 150 mg/mL
(p > 0.05) (Fig.1).
Conclusions: These results indicate PRG4’s disulﬁde bonded multi-
meric structure contributes to its ability to function as a dose-
dependent cartilage boundary lubricant, and is consistent with higher
order protein structure and disulﬁde bonding being necessary for
PRG4’s cartilage boundary lubricating ability. Interestingly, PRG4-mono
and PRG4-multi had similar boundary lubricating ability at the lower
(45, 150 mg/mL) concentrations. However, PRG4-mono at 450 mg/mL didnot further reduce friction compared to 150 mg/mL, whereas PRG4-
multi did and also possessed similar lubricating ability to that of whole
PRG4 at the physiological concentration of 450 mg/mL. Future studies
are required to determine the role these properties play in PRG4’s
ability to synergistically interact with hyaluronan to further lower
friction to levels near that of whole SF.
Signiﬁcance: Elucidating the PRG4 structure-lubrication function
relationship, both alone and with other SF constituents such as hya-
luronan, will further contribute to the understanding of PRG4’s role in
diarthrodial joint homeostasis and disease.
Figure 1. < mkinetic,Neq> friction coefﬁcients at Tps ¼ 1.2 s of PRG4-
mono and PRG4-multi at 45, 150 and 450 mg/mL. Where * is p < 0.01 and
** is p < 0.05 for PRG4-multi. There are no signiﬁcant differences across
the different concentrations for PRG4-mono. (ANOVA with Fisher’s post-
hoc). Sample size, n ¼ 4–8.
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ELIMINATION OF BMP7 EXPRESSION FROM THE LIMB ENHANCES
ARTICULAR CARTILAGE DEGENERATION AND SYNOVIAL
HYPERPLASIA IN ADULT MICE
K. Abula y, T. Muneta y, K. Miyatake y, J. Yamada y, Y. Matsukura y,
M. Inoue z, I. Sekiya x, D. Graf k, A. Economides{, V. Rosen#, K. Tsuji yy.
yDept. of Joint Surgery and Sports Med., Tokyo Med. and Dental Univ.,
Tokyo, Japan; zDept. of Plastic Reconstructive and Aesthetic Surgery,
Tokyo Med. and Dental Univ., Tokyo, Japan; xCtr. for Stem Cell and
Regenerative Med. , Tokyo Med. and Dental Univ., Tokyo, Japan; k Inst. of
Immunology, BioMed. Sci. Res. Ctr., Athens, Greece; {Regeneron
Pharmaceuticals, Inc, Tarrytown, NY, USA; #Dept. of Dev.al Biology,
Harvard Sch. of Dental Med., Boston, MA, USA; yyDept. of Cartilage
Regeneration, Tokyo Med. and Dental Univ., Tokyo, Japan
Purpose: While the potentials of recombinant bone morphogenetic
protein 7 (rhBMP7) in articular cartilage homeostasis are well recog-
nized through its anabolic, anti-apoptotic, anti-catabolic and anti-
inﬂammatory effects, analyses of the physiological roles of endogenous
Bmp7 has been hampered by the perinatal lethality of Bmp7 knockout
mice due to the kidney defect. To overcome these problems, we
employed conditional deletion of Bmp7 from the limb prior to the onset
of skeletogenesis during embryonic development. In this study, we
showed that endogenous Bmp7 has important roles for the joint
homeostasis.
Methods: Limb speciﬁc Bmp7 conditional knockout (:7CKO) mice were
created by breeding the mice carrying ﬂoxed Bmp7 with Prx1::cre
transgenic mice. Littermates those do not carry cre recombinase were
designated as control (Cont) mice. Whole knee joints of :7CKO and Cont
micewere harvested at 4 (n¼ 3 each), 8 (n¼ 7 each) and 24 (n¼ 9 each)
weeks of age. For the histological analyses, sagittal sections of the knee
joint were stained with safranin O-fast green or Hematoxylin and Eosin
(H/E). The severity of cartilage degeneration was evaluated by modiﬁed
Mankin’s score system. The severity of synovitis was evaluated by
synovitis score system. Articular cartilage structure such as thickness
and chondrocyte number was analyzed by Zeiss Axiovision Image
analysis system. For the immunohistochemical analyses, anti-mouse
